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ABSTRACT 
The immune response to Porphyromonas gingivalis, one of the key pathogens in 
periodontitis etiology, was analyzed activating naïve CD4+ T cells from healthy 
individuals with autologous dendritic cells pulsed with different P. gingivalis serotypes. 
Whereas serotypes K1 or K2 triggered a Th1/Th17 response, serotypes K3, K4 or K5 
triggered a Th2 response, and K- a Treg phenotype. We found a good correlation 
between the secreted cytokines and expression of the master switch transcription factors 
T-bet and RORC2 in response to K1 or K2, or with GATA-3 and the secreted cytokines 
in response to K3-K5. However, there was no correlation between expression of Foxp3 
and secretion of IL-10 or TGF-β1 on response to K-. In addition, T cells responding to 
K1 or K2, but not to the other serotypes led to an increased secretion of RANKL, a key 
cytokine involved in bone metabolism. Although the data could not be simply explained 
by differences in the frequency of T cells able to respond to the different serotypes on 
healthy and periodontitis affected individuals, it allowed to link serotypes K1 and K2 to 
the Th1/Th17 response and bone resorption characteristic of periodontitis. 
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 Introduction 
Periodontitis is an infectious disease characterized by chronic inflammation of the 
tissues around the teeth, causing destruction of these tissues and as a consequence, teeth 
loosening. It is a very common disease (prevalence 30-50% of the population in the 
US), elicited by the bacteria residing at the subgingival biofilm (1). Despite the broad 
variety of bacterial strains identified within the subgingival biofilm  (~500), only a few 
have been identified as etiological pathogens of periodontitis (2-4). In fact, the Gram-
negative bacteria Aggregatibacter actinomycetemcomitans and Porphyromonas 
gingivalis, both present in the subgingival biofilm have been described as the primary 
etiological agents of periodontitis (5-16). In particular, the significant association of P. 
gingivalis with the most severe forms of periodontitis and of its numbers with 
periodontal pocket depth (5, 7-10, 17-19), allowed the association of this bacteria with 
progressive tissue destruction (20, 21). Furthermore, differences in the prevalence and 
distribution of different P. gingivalis capsular (K) serotypes described so far (K1-K6 
and K-) have also been reported (22, 23).  
The interest on analyzing the immune response to periodontitis-associated bacteria 
comes from the fact that although the bacteria can cause some direct tissue damage, 
their pathogenicity mainly relies on the induction of a host immuno-inflamatory 
response, which leads to destruction of periodontal ligament, cementum and alveolar 
bone, finally leading to tooth loss (24-27). Indeed, an increase in the number of 
dendritic cells and T lymphocytes has been described within the inflammatory site 
during periodontal infections (28-30), where dendritic cell maturation and subsequent 
antigen presentation to naïve T cells has been suggested to take place in situ (24). The 
data regarding the immune response to periodontitis remains, however, controversial. In 
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some reports, a Th1-type immune response has been associated with active 
periodontitis, whereas a Th2-type response was associated with remission (31-37). 
Conversely, other reports associate a stable periodontal lesion with a Th1-type response, 
whereas active progression was associated with a Th2-type response (38-44). More 
recently, a Th17-type of response has been associated with periodontitis-induced tissue 
destruction (45-49) and Treg cells have been suggested to protect from periodontitis 
(50-52). 
We have previously analyzed the response in vitro of DCs, generated from 
peripheral blood monocytes from normal donors to different capsular serotypes of P. 
gingivalis, demonstrating quantitative differences in the response of DCs to different K 
serotypes (53). In this context, we speculated that different P. gingivalis serotypes might 
lead to a differential T lymphocyte activation and/or to a different type of T-cell 
immune response generated. In the present investigation, the synthesis of cytokines and 
the expression of the transcription factors T-bet, GATA-3, RORC2 and Foxp3, the 
master-switch genes controlling Th1, Th2, Th17, and Treg differentiation, respectively, 
were analyzed on human T lymphocytes activated with different P. gingivalis K 
serotypes, demonstrating that different serotypes lead to expression of different master-
switch genes and secretion of different cytokine patterns. 
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Results 
Antigen-specific activation of T lymphocytes with autologous DCs 
Highly purified monocytes (>98% CD14+) isolated from peripheral blood were 
differentiated into DCs upon culture in presence of IL-4 and GM-CSF, obtaining a 
highly pure population of DCs (>97%), as demonstrated by the expression of the CD1a, 
the increase in CD86 expression and the concomitant loss of the monocyte-macrophage 
marker CD14 as quantified by flow cytometry (Figure 1A). These DCs where then 
stimulated at an MOI of 103 with P. gingivalis serotype K1 (see materials and methods 
for the complete description of the different K serotypes), and the efficiency of DC 
maturation (>96%) was confirmed by the increased expression of CD83 and CD80 
antigens, associated with an increase in cell size (not shown). These cells were used to 
activate highly purified populations of autologous naïve T lymphocytes (>98% CD4+) 
isolated from peripheral blood (Figure 1B) with a T-cell:DC ratio of 50:1. As early as 1 
day upon T lymphocyte activation, an increase on CD25 and CD69 expression was 
observed on a subpopulation of T cells, as compared to the same T lymphocytes 
exposed to non-induced DCs, reaching levels >10% 5 days after. Indeed, expression of 
the early activation marker CD69 increased >10-fold 1 day after T-lymphocyte 
induction, reaching plateau levels at day 2. These changes were concomitant with the 
expression levels of CD25, the inducible α-subunit of the IL-2R, that increased >5-fold 
5 days after T-lymphocyte activation. Conversely, the expression levels of CD62L (L-
selectin), a leukocyte adhesion molecule member of the homing receptor family that is 
lost after cell activation, decreased >7-fold 5 day after T-cell activation (Figure 2A). 
Similar results were found with T cells activated with DCs triggered with P. gingivalis 
strains K1-K6 or K- (not shown). These data were further confirmed by quantitative RT-
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PCR analysis of CD25 mRNA expression, where a ≥10-fold increase on CD25 mRNA 
expression was observed on T lymphocytes activated by P. gingivalis serotypes K1-K6 
or K- primed DCs as compared with T lymphocytes exposed to non-induced DCs or 
non-induced T cells. Furthermore, no significant differences were detected when T 
lymphocytes were activated by DCs primed with any of the encapsulated or non-
encapsulated P. gingivalis serotypes (Figure 2B). 
Cytokine mRNA expression and secretion by P. gingivalis-activated T cells 
On T lymphocytes activated with autologous DCs primed with different P. gingivalis 
serotypes at different MOI, the expression levels for several cytokine mRNAs was 
determined by RT-quantitative real-time PCR. The data represented as fold-change for 
each condition reveal a dose-dependent increase in the expression levels for the 
different cytokines analyzed (Figure 3). The T cell response against serotypes K1 or K2 
was characteristic of a Th1 phenotype, as demonstrated by the over-expression of IL-1β, 
IFN-γ, IL-12p35, IL12-p40, TNF-α, and TNF-β mRNAs (at MOIs of 0.1-103 p<0.05) 
concomitant with unchanged levels on the expression of cytokines associated to other 
phenotypes (IL-4, IL-5, IL-13, IL-10 or TGF-β1). Higher expression levels for IL-2 
mRNA (at MOIs of 102 and 103 p<0.05) were also detected when cells were activated 
with these serotypes as compared with K- or K3-K6. Interestingly, K1 and K2 serotypes 
also over-expressed mRNAs for the cytokines characteristic of the Th17 phenotype, 
namely IL-6, IL-17 and IL-23 mRNAs (at MOIs of 0.1-103 p<0.05). Conversely, when 
the same T cells were activated with autologous DCs primed with P. gingivalis 
serotypes K3, K4 or K5, the observed cytokine expression pattern on T-lymphocytes 
was characteristic of a Th2 phenotype. Indeed, higher expression of IL-4 and IL-5 
mRNA levels (at MOIs of 102 and 103 p<0.05), without changes in the expression of 
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cytokines of the Th1, Th17 or Treg phenotypes (IL-1β, IFN-γ, IL-12p35, IL12-p40, 
TNF-α, TNF-β, IL-10 or TGF-β1). The expression of IL-13, however, was not 
increased in any experimental condition. 
Overall, upon T lymphocyte activation with DCs primed with capsulated P. gingivalis 
strains K1 or K2, a T cell response biased towards a Th1/Th17 phenotype was detected, 
whereas a Th2 cytokine expression profile was detected when the same cells were 
activated with strains K3-K5. Furthermore, the same T lymphocytes activated with DCs 
primed with the K- strain over-expressed only the mRNAs coding for IL-10 and TGF-β1 
(at an MOI of 103 p<0.05), denoting a regulatory immune response. 
These distinct patterns of response were confirmed at the protein level upon the 
analysis of cytokines secreted into the culture supernatants (Figure 4). Higher levels of 
the typical Th1 cytokines IL-1β, IL-2, IFN-γ, IL-12p40, IL12-p70, TNF-α, and TNF-β 
were detected when cells were activated at an MOI of 103 with serotypes K1 or K2 as 
compared to the other serotypes. Similar results were obtained with these strains for the 
typical Th17 cytokines IL-6, IL-17 and IL-23, although for the latest, the data was 
significant only for T cell stimulated with the K1 serotype. Conversely, higher levels of 
IL-4 and IL-5 were detected in T lymphocytes activated with serotypes K3, K4 or K5 as 
compared with the others. IL-13 secretion was also higher with cells stimulated with 
K3, K4 or K5, although it was statistically significant only in T lymphocytes activated 
with K3. Finally, higher secreted levels of IL-10 were detectable on the supernatants of 
T cells activated with the K- strain of P. gingivalis, as compared to the response to 
encapsulated serotypes; this response could be associated to a regulatory lymphocyte 
response. 
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Transcription factor mRNA expression 
Since the data obtained was consistent with a differential induction of T lymphocyte 
phenotypes triggered upon activation with different P. gingivalis serotypes, we decided 
to confirm these data with the expression levels of the master-switch transcription 
factors T-bet, GATA-3, RORC2 and Foxp3, determined by quantitative real-time PCR 
on mRNAs from T lymphocytes activated by autologous DCs primed (MOIs of 102 or 
103) with the different P. gingivalis serotypes. The data obtained, represented in Figure 
5 show a significant increase of T-bet and RORC2 mRNAs in T lymphocytes activated 
with serotypes K1 or K2 (MOIs of 102 or 103 p<0.05), as compared to the same T cells 
activated with other serotypes. In addition, GATA-3 mRNA levels were increased 
exclusively upon T cell activation with K3, K4 or K5 serotypes as compared with 
others, although the differences were only significant for an MOI of 103 (p<0.05). 
Furthermore, Foxp3 mRNA expression was increased in T lymphocyte mRNAs 
following activation with the K- strain (at MOIs of 102 and 103 p<0.05). 
The correlation analyses between the expression of these transcription factors and 
the secreted cytokines on each activation condition tested (Table 2) yielded significant 
positive correlation between T-bet expression and Th1-associated cytokine secretion 
(IL-1β, IL-2, IL-12, IFN-γ, TNF-α, and TNF-β) when T lymphocytes were activated 
with K1 or K2-primed DCs. Under the same conditions, a positive correlation was also 
observed between RORC2 and Th17-associated cytokines (IL-6, IL-17, and IL-23). A 
significant positive correlation was also detected between GATA-3 and Th2-associated 
cytokines IL-4 and IL-5 when T lymphocytes were activated with serotypes K3, K4 or 
K5, although IL-13 was positively correlated only with K3-activated T lymphocytes. 
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Conversely, Foxp3 expression did not show any positive correlation with IL-10 or TGF-
β1 secretion. 
RANKL mRNA expression and secretion in response to P. gingivalis 
Since periodontitis progression is characterized by bone tissue destruction, eventually 
leading to loosening of the teeth, we analyzed the expression levels of RANKL, a 
cytokine associated with this process. The data obtained showed an increase in RANKL 
mRNA expression on T cells activated with K1 or K2 (differences significant only for 
K1), but not with K3-K6, nor with K- (Figure 6A). These data strictly correlate with the 
levels of secreted RANKL, present in the supernatant of these cultures (Figure 6B), 
although at the protein level, the differences were statistically significant for both K1 
and K2. Correlation analyses between mRNA expression levels of the transcription 
factors T-bet, GATA-3, RORC2 or Foxp3 and secreted RANKL yielded positive 
correlation between T cells stimulated with K1 and K2 with the transcription factors T-
bet and RORC2, although it was statistically significant only with cells stimulated with 
K1 (Figure 6C). On T cells stimulated with K3-K6 or K- the correlation was negative 
(not shown), as well as with cells stimulated with K1 or K2 with the transcription 
factors GATA-3 and Foxp3. Taken together, these data suggests a link between K1 and 
K2 serotypes of P. gingivalis with cytokines involved in bone resorption. 
To ascertain whether there differential response of T cells to the different serotypes 
were due to differences in the number of T lymphocytes able to respond to them, 
limiting dilution analyses were performed to determine the frequency of T cells able to 
respond to K1, K2, K4 or K- in T lymphocytes purified from both healthy and 
periodontitis affected patients. The data obtained showed a 3-fold lower frequency of T 
cells able to respond to K4 (p=0.024) and K- (p=0.006) on periodontitis patients as 
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compared to healthy individuals (frequencies ranging from 1/48429 to 1/37627 in 
healthy individuals, and 1/111,373 to 1/103,364 in periodontitis patients). The 
frequencies of T cells able to respond to antigens from K1 or K2 ranged from 1/49,601 
to 1/69,688 and did not give, however, significant differences between healthy 
individuals and periodontitis patients (Figure 7). 
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Discussion 
Although historically disease progression in chronic inflammatory diseases had 
been ascribed to particular Th phenotypes, emerging data indicate that more than one 
phenotype can coexist, for example in multiple sclerosis and rheumatoid arthritis, two 
diseases initially described as typical Th1, the implication of the Th17 phenotype has 
recently been described (54, 55). In periodontitis, it has been difficult to determine 
which T cell subset, and specific cytokine profiles are destructive and lead to tissue 
damage, and which ones are associated with disease resolution (24, 25). In particular 
since the presence of multiple bacteria, including commensal strains, can modify or 
even switch from a T cell-type of response to another (56, 57). This has led to 
conflicting reports, ones suggesting a Th1/Th17 dominated response in periodontal 
disease (32, 33, 36, 45, 46), whereas in others, a Th2 host response was associated with 
either progressive disease (38) or remission (35). 
Aiming to analyze the role of T-cell immune responses in periodontitis, in particular 
on T-lymphocyte cytokine profiles at the local inflammation site, we used an in vitro 
system, in which differences between the analyzed samples were restricted to the use of 
different capsular serotypes of P. gingivalis. It is obvious that this system can only be 
used as a model since it represents an oversimplification of the in vivo situation, but 
fulfilled the requirements to unravel some insights on controversial issues regarding the 
immune response to periodontitis. Previous data on DC response to different P. 
gingivalis serotypes demonstrated a differential stimulation potential, but did not show 
significant differences on the type of response (53). In contrast, the data presented here 
on T cells activated with autologous DCs stimulated with different P. gingivalis 
serotypes has shown that serotype differences led to expression of distinct cytokine sets, 
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as determined both as mRNA expression and secreted cytokines into the cell culture 
supernatants (Figures 3,4). These data suggested that activation of T cells with DCs 
stimulated with either K1 or K2 induced a Th1/Th17 phenotype in CD4+ T cells, 
whereas the serotypes K3-K5 led to the secretion of Th2-type cytokines. The data with 
K6 and K- were, as discussed below, less straightforward. Further corroboration of the 
activation of CD4+ T cells towards distinct phenotypes came from mRNA expression 
analyses of the master switch transcription factors T-bet, GATA-3, RORC2 and Foxp3. 
T-bet and RORC2 were specifically up-regulated on T cells activated with the serotypes 
K1 or K2, GATA-3 was specifically up-regulated on T cells activated with serotypes 
K3, K4 or K5, whereas Foxp3 was up-regulated on T cells activated with K-. Although 
the up-regulation of the activation marker CD25 (Figure 2B) or the proliferation (not 
shown) of T cells activated with K6 was comparable to the levels obtained with other P. 
gingivalis serotypes, this serotype did not lead to up-regulation of any of these 
transcription factors, nor lead to secretion of any of the cytokines analyzed, and thus, 
K6 could not be associated to any of the known helper-T cell phenotypes. 
Correlation analyses between the levels of secreted cytokines and expression levels of 
the master switch transcription factors T-bet, RORC2, GATA-3 and Foxp3 where 
highly informative since they showed that expression of the transcription factor Foxp3 
and secreted IL-10 or TGFß1 were devoid of statistic significance, suggesting that these 
cells did not represent bona-fide induced-regulatory T cells. Conversely, there was a 
positive correlation between GATA-3 and Th2-cytokines in T cell samples activated 
with K3-K5, although the data for IL-13 was significant only for K3. Similarly, there 
was a positive correlation between T-bet and the classical Th1-cytokines as well as 
between RORC2 and Th17-cytokines in T cell samples activated with either K1 or K2, 
but not with K3-K6 nor K-. In addition, the lack of correlation between T-bet and Th17 
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cytokines or between RORC2 and Th1-cytokines (supplementary Figure 1) indicated 
that the serotypes K1 and K2 were able to activate CD4+ T cells towards either a Th1 or 
a Th17 phenotype, rather than to a dual Th1/Th17 phenotype. 
Elevated RANKL levels have been found in the gingival crevicular fluid from 
periodontitis patients (58, 59). It has also been demonstrated that this cytokine is 
secreted within the inflammation site by T cells (60). We demonstrated that RANKL 
mRNA up-regulation and/or secretion correlated with K1 and K2 serotypes, but not 
with the others. Furthermore, there was a significant correlation between RANKL 
secretion and RORC2 (for K1), but not with the other master switch transcription 
factors (the correlation was positive but not significant for K2 and RORC2, as well as 
for K1 or K2 and T-bet). These data demonstrated that RANKL secretion by T cells was 
restricted to particular P. gingivalis serotypes (namely K1 and K2), and allowed to 
suggest a link between these serotypes with alveolar bone destruction and teeth 
loosening, one of the hallmarks of periodontitis. 
Limiting dilution analyses to determine the frequency of T lymphocytes able to respond 
to K1, K2, K4 or K- in both healthy and periodontitis-affected individuals led to identify 
a significant lower frequency of T cells able to respond to K- and K4 in healthy as 
compared to periodontitis-affected individuals, but there were no significant differences 
on the frequency of T cells able to respond to K1 or K2. We do not know the reason for 
the lack of differences, but might be due to the use of whole bacteria instead of specific 
antigens for the stimulation, leading to a large number of different antigens being 
presented, where the antigens of interest might represent only a small fraction. 
Since the host-pathogen interaction is highly dynamic, and it is known that the 
extracellular capsule enables bacteria to withstand phagocytosis (61), it comes to no 
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surprise that a given pathogen evolves generating changes in its capsule. Six different 
capsular serotypes (K1-K6) and a strain devoid of capsule (K-) have been described 
from isolates of P. gingivalis. These different capsular serotypes induced distinct T cell 
responses, some leading to a Th1- and Th17-type phenotype whereas others trigger a 
Th2-type phenotype in the host T cells. These data allow suggesting that P. gingivalis 
by simply changing the ratio of different serotypes within the periodontal lesion can 
modulate the host immune response to prevent its clearance. Furthermore, it can also be 
speculated that changes in serotype ratio can be related to the alveolar-bone destructive 
bursts in specific sites, which could be due to an increase of K1 or K2 and the 
concomitant RANKL secretion. 
Taken together, these data suggest that in active periodontitis sites, microbiological 
diagnosis should aim towards determining serotype composition, instead of seeking the 
identification of pathogenic species. Furthermore, these findings may allow to envisage 
new therapeutic approaches focusing on modulating the host response, instead of 
decreasing the bacterial challenge, which is the current clinical periodontal practice. 
Since it may be possible to discriminate between a protective and a destructive host 
response in periodontitis, therapeutic immune-intervention could focus on stimulating 
the protective and on inhibiting the destructive aspects of the periodontal T-lymphocyte 
immune response.   
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Materials and Methods 
P. gingivalis growth conditions and curves 
P. gingivalis from different serotypes have been used, these are serotype K1 (strain 
W83), serotype K2 (strain HG184), serotype K3 (strain A7A1-28), serotype K4 (strain 
ATCC-49417), serotype K5 (strain HG1690), serotype K6 (strain HG1691), and the 
strain devoid of capsule K- (strain ATCC-33277), from which the different P. gingivalis 
serotypes were initially described. The growth curves were determined in order to 
obtain a reliable number of colony-forming units for DCs stimulation, as described 
previously (62). 
Human peripheral blood samples. 
The research described here was approved by the authors institutional review board. 
Human peripheral blood mononuclear cells (PBMCs) were obtained from buffy coats 
(from the Madrid Regional Blood Bank). Healthy donors and periodontitis diagnosed 
patients, to whom the protocol of the study was clearly explained, agreed to participate 
by signing an IRB-approved informed consent form. 
Monocyte purification and DCs differentiation and stimulation 
Human peripheral blood mononuclear cells (PBMCs) were isolated from peripheral 
blood from healthy donors or periodontitis diagnosed patients over a Ficoll gradient 
(Ficoll-Paque Plus; Amersham Pharmacia Biotech, Uppsala, Sweden) by using standard 
procedures. Monocytes were purified from PBMCs by magnetic cell sorting (MACS; 
Miltenyi Biotec, Bergisch Gladbach, Germany), using an anti-CD14 mAb conjugated to 
magnetic beads, and immediately subjected to a DC differentiation protocol described 
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previously (62). Differentiated DCs were then primed with increasing multiplicity of 
infection (MOI) of 0.1-103 (bacteria/DCs ratio) of the encapsulated P. gingivalis strains 
K1-K6 for 2 days. DCs primed with the same MOIs of the non-encapsulated strain K- of 
P. gingivalis or 10 ng/ml of E. coli 0111:B4 LPS (Fluka, Sigma-Aldrich Chemie, 
Buchs, Switzerland) were used for comparison. Non-induced DCs served as control. 
T-lymphocyte purification and activation 
CD4+ T lymphocytes were obtained from peripheral blood samples by immuno-
magnetic depletion. In PBMCs, non-T helper and memory T helper cells were indirectly 
magnetically labeled with a cocktail of biotin-conjugated mAbs and an anti-biotin mAb 
conjugated to magnetic beads (Miltenyi Biotec) to obtain a purified population of naïve 
CD4+ T lymphocytes. For activation, 106 cells/ml T lymphocytes were cultured with 
autologous primed DCs (50:1) in RPMI-1640 containing 10% FCS for 5 days at 37ºC. 
T-lymphocyte cultures devoid of DCs or cultured with non-induced DCs were used as 
controls. 
Phenotypic analyses 
The monocyte purification efficiency, their differentiation towards DCs and their 
subsequent stimulation were monitored as described previously (60). Cells were stained 
with PE, FITC or PE/Cy5-labelled anti-CD14, CD1a, CD80, CD83, or CD86 mAbs 
(BD Biosciences Pharmingen, San José, CA, USA) and analyzed by flow cytometry 
(EPICS XL, Beckman Coulter, Fullerton, CA, USA). T lymphocyte purity was 
determined using PE or FITC-labeled anti-CD14 and anti-CD4 mAbs (BD Biosciences 
Pharmingen).  
Kinetics of T-lymphocyte activation 
 
17 
For analysis of T-lymphocyte activation, T lymphocytes (106 cells/ml) were stimulated 
with P. gingivalis strain K1-primed DCs (50:1) and analyzed at different times (0-5 
days). As control, non-induced DCs were used. Cells were stained with PE- or FITC-
labeled anti-CD25, anti-CD62L, or anti-CD69 mAbs (BD Biosciences Pharmingen) and 
analyzed by flow cytometry. 
mRNA expression analyses 
Cytoplasmic RNA was isolated from T lymphocytes using the NP-40 method as 
described previously (63). Reverse transcription was performed using a Transcriptor 
First Strand cDNA synthesis kit following the manufacturer’s recommendations (Roche 
Applied Science, Mannheim, Germany). To quantify the mRNA expression for the 
cytokines IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p35 and p40), IL-13, IL-17, IL-
23, IFN-γ, TNF-α, TNF-β, and TGF-β1, the transcription factors T-bet, GATA-3, 
RORC2, and Foxp3, as well as α chain of the IL2-Rec CD25, 50 ng of cDNA were 
amplified by quantitative real-time PCR in 384-well plates, using the appropriate 
primers and probes (Table 1) and the FastStart Taqman Probe Master (Roche), in an 
ABI PRISM 7900 Sequence Detector System (Applied Biosystems, Foster City, CA, 
USA), as described previously (63). In all cases, 18S rRNA expression levels were used 
as endogenous control. 
Cytokine secretion 
After stimulation for 5 days, T-lymphocyte culture supernatants were collected and the 
secretion of IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-13, IFN-γ, TNF-α, and 
TNF-β was measured using a multiplex bead-based assay according the manufacturer’s 
protocols (Linco/Millipore Corp., Billerica, MA, USA). Secretion of IL12p70 
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(OptEIATM, BD Biosciences, San Diego, CA, USA), IL-17, IL-23, and TGF-β1 
(Quantikine®, R&D Systems Inc., Minneapolis, MN, USA) were analyzed by ELISA 
according manufacturer’s protocols and measured with an automatic microplate 
spectrophotometer (Labsystem Multiskan, Helsinki, Finland) at 492 nm. 
Limiting dilution analysis 
To determine the frequency of CD4+ T lymphocytes able to get activated in 
response to different P. gingivalis strains, CD4+ T lymphocytes were isolated from 3 
chronic periodontitis patients and 3 healthy controls. 106 lymphocytes/ml were cultured 
with autologous DCs primed with P. gingivalis strain K-, K1, K2 or K4. DCs were 
added to the T-lymphocyte cultures in a 1:50 ratio. T cells were transferred to 96-well 
round-bottom microtiter plates and plated at log 3 dilutions in 200 µl/well RPMI-1640 
for 5 d. After 4 d incubation, 1µCi/well [methyl-3H]thymidine ([3H]TdR; Hartmann 
Analytic GMBH, Braunschweig, Germany) was added and beta emission was counted 
24 h later. T lymphocytes exposed to non-induced DCs were used as control. For LDA, 
[3H]TdR incorporation was considered positive when the detected counts exceeded the 
mean counts of control by more than 3 SD as described previously (64). 
Data analyses 
The flow cytometry data were analyzed using the WinMDi 2.9 software (The Scripps 
Research Institute, La Jolla, CA, USA), represented as histograms and expressed as 
percentage of positive cells. The quantitative PCR data were analyzed using the 
ABIPRISM software (Applied Biosystems) and the relative quantification was obtained 
using the 2-ΔΔCt method after normalization of the expression from the mRNA of interest 
with 18S rRNA levels (65). For LDA, the frequency of wells with cells able to 
 
19 
proliferate in each experimental condition was determined by assuming a Poisson 
single-hit model and represented showing the estimated responding cells per well and 
the frequency of negative cultures (66). Data were statistically analyzed using the SPSS 
15.0 software (Lead Technologies Inc., Charlote, NC, USA). The normality of data 
distribution was determined using the Shapiro-Wilk test. Differences regarding CD-
expression levels analyzed by flow cytometry were determined using the Chi-square 
test. Differences between groups and within each group regarding the cytokine, 
transcription factor and CD25 mRNA expression as well as the cytokine secretion were 
determined using the unpaired Kruskal Wallis test or ANOVA and Tukey tests. 
Correlation coefficients were obtained using the Pearson test. Statistical significance 
was assumed when p < 0.05. 
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Figure legends 
Figure 1. Phenotypic analysis of monocytes, dendritic cells (DCs) and T lymphocytes. 
(A) Flow cytometry analyses of CD14, CD1a, CD86, CD83, and CD80 to ascertain the 
purity of monocytes isolated from peripheral blood mononuclear cells (PBMCs), the 
efficiency of monocyte differentiation towards DCs in presence of 1000 U/ml IL-4 and 
GM-CSF and their subsequent maturation after a 48-h stimulation at a multiplicity of 
infection (MOI) of 103 with Porphyromonas gingivalis strain K1 W83. (B) Flow 
cytometry analyses of CD4 and CD14 expression demonstrating the purity of naïve 
CD4+ T lymphocytes isolated from PBMC. The histograms shown are from a 
representative experiment. The values on each histogram expressed as percentage of 
positive cells represent the mean ± SD from 10 independent experiments. 
Figure 2. Kinetics of T-lymphocyte activation. (A) T-cell activation was analyzed 
following expression of cell surface markers CD25, CD62L and CD69 by flow 
cytometry in T lymphocytes activated by dendritic cells (DCs) primed at a multiplicity 
of infection (MOI) of 103 with Porphyromonas gingivalis strain K1 W83 for 5 days 
(K1). Expression of activation markers in T lymphocytes exposed to non-induced DCs 
were used as control (n.i.). The histograms shown are from a representative experiment. 
The values on each histogram expressed as percentage of positive cells represents the 
mean ± SD from 5 independent experiments. Similar results were found when T 
lymphocytes were activated with the different P. gingivalis serotypes. (B) RT-
quantitative PCR analysis for the CD25 mRNA expression in T lymphocytes activated 
by dendritic cells (DCs) primed at a multiplicity of infection (MOI) of 103 with the 
encapsulated (K1-K6) or non-encapsulated (K-) strains of P. gingivalis. For relative 
expression, the CD25 mRNA expression in T lymphocytes cultured in the absence of 
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DCs was considered as 1, as a reference for fold-change in expression. Comparisons 
were done versus T lymphocytes exposed to non-induced DCs (*p < 0.05). Data are 
represented as fold-change for 10 independent experiments. The box plots show the 
medians, 1st and 3rd quartiles as boxes and 10th and 90th percentiles as whiskers. Outliers 
are show as open circles.  
Figure 3. Cytokine mRNA expression. Quantitative PCR analysis for the cytokine 
mRNA expression in T lymphocytes activated by dendritic cells (DCs) primed with 
increasing multiplicity of infection (MOI) of encapsulated (K1-K6) or non-encapsulated 
(K-) strains of Porphyromonas gingivalis. Black squares correspond to cytokine mRNA 
expression in T lymphocytes activated by DCs primed with E. coli LPS, used as 
positive control (LPS). For relative expression, the cytokine mRNA expression in T 
lymphocytes exposed to non-induced DCs was considered as 1, as a reference for fold-
change in expression (not shown). Data are represented as fold-change and represented 
as mean ± SD for 7 independent experiments. *p < 0.05. 
Figure 4. Cytokine secretion levels. Secreted cytokines into the supernatants from the T 
lymphocyte cultures used for Figure 3 (the condition represented is MOI of 103) with 
the different K strains. Secreted cytokine levels by T lymphocytes exposed to non-
induced DCs were used as control (n.i.). Data are represented as cytokine concentration 
(pg/ml) from 10 independent experiments. The box plots show the medians, 1st and 3rd 
quartiles as boxes; 10th and 90th percentiles are represented as whiskers. *p < 0.05. 
Figure 5. Transcription factor mRNA expression. Quantitative PCR analysis for the T-
bet (Th1), GATA-3 (Th2), RORC2 (Th17), and Foxp3 (Treg) mRNA expression in T 
lymphocytes activated by dendritic cells (DCs) primed at a multiplicity of infection 
(MOI) of 103 with encapsulated (K1-K6) or non-encapsulated (K-) strain of 
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Porphyromonas gingivalis. For relative expression, the transcription factor mRNA 
expression in T lymphocytes exposed to non-induced DCs was considered as 1, as a 
reference for fold-change in expression (n.i.). Data are represented as fold-change from 
7 independent experiments. The box plots show the medians, 1st and 3rd quartiles 
represented as boxes and 10th and 90th percentiles represented as whiskers. *p < 0.05. 
Figure 6. RANKL mRNA expression and secretion levels. (A) Quantitative PCR 
analysis for the RANKL mRNA expression in T lymphocytes activated by dendritic 
cells (DCs) primed with increasing multiplicity of infection (MOI) of encapsulated (K1-
K6) or non-encapsulated (K-) strains of P. gingivalis. Black squares correspond to 
cytokine mRNA expression in T lymphocytes activated by DCs primed with E. coli 
LPS, used as positive control (LPS). For relative expression, the cytokine mRNA 
expression in T lymphocytes exposed to non-induced DCs was considered as 1, as a 
reference for fold-change in expression (not shown). Data are represented as fold-
change and represented as mean ± SD for 7 independent experiments. *p < 0.05. (B) 
Secreted RANKL into the supernatants from the T lymphocyte cultures used for Figure 
6A (the condition represented is MOI of 103) with the different K strains. Secreted 
RANKL levels by T lymphocytes exposed to non-induced DCs were used as control 
(n.i.). Data are represented as cytokine concentration (pg/ml) from 10 independent 
experiments. The box plots show the medians, 1st and 3rd quartiles as boxes; 10th and 
90th percentiles are represented as whiskers. Outliers are show as open circles. *p < 
0.05. (C) Correlation analyses of RANKL mRNA expression and secretion in T 
lymphocytes activated by DCs primed at a MOI of 103 with serotypes K1-K2 of P. 
gingivalis. 
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Figure 7. Frequency of T lymphocytes able to respond to different P. gingivalis 
serotypes. Frequency of CD4+ T lymphocytes able to respond to K1, K2, K4 or K- P. 
gingivalis serotypes in healthy individuals and periodontitis patients determined by 
limiting dilution analyses. Different T lymphocyte concentrations were cultured with 
autologous DCs primed with P. gingivalis strains K-, K1, K2 or K4. The frequency of 
wells with proliferating cells in each experimental condition was determined by 
[3H]TdR incorporation and LDS analysis and represented showing the estimated 
responding cells per well and the frequency of negative cultures. 
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Table 1. Primers and PCR probes used for quantitative real-time PCR 
mRNA Forward Primer Reverse Primer PCR Probe* 
IL-1β ctgtcctgcgtgttgaaaga ttgggtaatttttgggatctaca 78 
IL-2 aagttttacatgcccaagaagg aagtgaaagtttttgctttgagc 65 
IL-4 caccgagttgaccgtaacag gccctgcagaaggtttcc 16 
IL-5 ctctgaggattcctgttcctgt cagtacccccttgcacagtt 47 
IL-6 gcccagctatgaactccttct gaaggcagcaggcaacac 45 
IL-10 tgggggagaacctgaagac ccttgctcttgttttcacagg 30 
IL-12p35 cactcccaaaacctgctgag tctcttcagaagtgcaagggta 50 
IL-12p40 ccctgacattctgcgttca aggtcttgtccgtgaagactcta 37 
IL-13 agccctcagggagctcat ctccataccatgctgccatt 17 
IL-17 tgggaagacctcattggtgt ggatttcgtgggattgtgat 8 
IL-23 agcttcatgcctccctactg ctgctgagtctcccagtggt 30 
IFN-γ ggcattttgaagaattggaaag tttggatgctctggtcatctt 21 
TNF-α cagcctcttctccttcctgat gccagagggctgattagaga 29 
TNF-β ctaccgcccagcagtgtc gtggtgtcatggggaga 13 
TGF-β1 cacgtggagctgtaccagaa cagccggttgctgaggta 72 
RANKL tgattcatgtaggagaattaaacagg gatgtgctgtgatccaacga 17 
T-bet tccaagtttaatcagcaccaga tgacaggaatgggaacatcc 9 
GATA-3 ctcattaagcccaagcgaag tctgacagttcgcacaggac 71 
RORC2 agaaggacagggagccaag caagggatcacttcaatttgtg 21 
Foxp3 Acctacgccacgctcatc tcattgagtgtccgctgct 50 
CD25 caagcgagccttccagatt ggccactgctacctggtact 46 
18S rRNA ctcaacacgggaaacctcac cgctccaccaactaagaacg 77 
*Number of the specific FAM dye-labeled probe (Roche). 
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Table 2. Correlation analyses of cytokine secretion and transcription factor mRNA 
expression 
  Pearson’s  correlation coefficient (r)** 
  K- K1 K2 K3 K4 K5 K6 
T-bet IL-1β  0.901* 0.916*     
 IL-2  0.815* 0.882*     
 IFN-γ  0.891* 0.941*     
 IL-12p40  0.845* 0.924*     
 IL-12p70  0.849* 0.886*     
 TNF-α  0.852* 0.969*     
 TNF-β  0.845* 0.813*     
GATA-3 IL-4    0.862* 0.930* 0.799* 0.538 
 IL-5    0.828* 0.795* 0.845* 0.435 
 IL-13    0.858* 0.746 0.734 0.463 
RORC2 IL-6  0.889* 0.936*     
 IL-17  0.900* 0.895*     
 IL-23  0.917* 0.962*     
Foxp3 IL-10 0.348       
 TGF-β1 0.269       
*p < 0.05 
**Pearson’s correlation coefficient (r) between the transcription factors T-bet, RORC2 
and Foxp3 and the secreted cytokines from activated T lymphocytes (at an MOI of 103 
with the different P. gingivalis serotypes) (n=7). Analyses that did not show a positive 
correlation are not shown (blank). 
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*** Correlations between T-bet and RORC2 with Th1 and Th17 cytokines for K1 and 
K2 are shown in supplementary Figure 1. 
 
38 
Figure S1. Correlation analyses of cytokine secretion and transcription factor T-bet and 
RORC2. Table 1 shows a positive correlation between T-bet and RORC2 with Th1 and 
Th17 cytokines. A detailed analyses of these correlations in K1 and K2 for each of these 
transcription factors with Th1 and Th17 cytokines show a positive correlation between 
T-bet and Th1 cytokines or between RORC2 and Th17 cytokines (red), and a lack of 
correlation between T-bet and Th17 cytokines or between RORC2 and Th1 cytokines 
(black). These data indicate that K1 and K2 are able to activate both Th1 and Th17 T-
cell clones. 
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